Home › Anemia falciforme › New York
Studi clinici su Anemia falciforme nello stato di New York
21 studi su Anemia falciforme cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
Testo ufficiale dello studio (inglese)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens Hospital at Montefiore, The Bronx
In reclutamentoFase 3
Età da 12 a 100 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Mount Sinai Hospital, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
In reclutamentoFase 3
Età 2 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- NYC Health+Hospitals, Brooklyn
- Interfaith Medical Center, Brooklyn
- Cohen Children's Medical Ctr, Queens
- e altri 2
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Icahn School of Medicine at Mount Sinai, New York
- Jacobi Medical Center, The Bronx
In reclutamentoFase 2/3
Età 12 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- e altri 2
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Mount Sinai Medical Center, New York
- Jacobi Medical Center, The Bronx
In reclutamentoFase 2
Età 12 e oltre · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Jacobi Medical Center, The Bronx
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Richmond University Medical Center- Site Number : 8400038, Staten Island
- Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
In reclutamentoFase 3
Età da 10 a 65 · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- New York Medical College, Valhalla
In reclutamentoFase 2
6 Months – 21 Years · Tutti i sessi · Aggiornato il 27 lug 2026 · NCT02675959Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
In reclutamentoFase 1/2
Età da 12 a 50 · Tutti i sessi · Aggiornato il 2 lug 2026 · NCT04819841131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
- Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età da 12 a 50 · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT07015684Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Roswell Park (MRD-HCT), Buffalo
- Columbia Presbytarian (NT-DMT), New York
- Cohen's Children Hospital (NT-DMT), Queens
- e altri 4
In reclutamentoStudio osservazionale
Età da 3 a 20 · Tutti i sessi · Aggiornato il 4 giu 2026 · NCT06941389A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
In reclutamentoFase 2
Età da 2 a 50 · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
In reclutamentoFase 3
Età da 12 a 35 · Tutti i sessi · Aggiornato il 23 mar 2026 · NCT05477563Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Columbia University, New York
In reclutamentoFase 2
Età da 2 a 25 · Tutti i sessi · Aggiornato il 10 mar 2026 · NCT03587272A Long-term Follow-up Study in Patients Who Received BEAM-101
- Columbia University Irving Medical Center, New York
In reclutamentoStudio osservazionale
Età da 14 a 37 · Tutti i sessi · Aggiornato il 28 gen 2026 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Weil Cornell Medical College, New York
- University of Rochester Medical Center, Rochester
In reclutamento
Età da 16 a 30 · Tutti i sessi · Aggiornato il 7 gen 2026 · NCT06374238Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
- Mount Sinai Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2025 · NCT05519111AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
In reclutamentoFase 2
1 Day – 30 Years · Tutti i sessi · Aggiornato il 8 ago 2025 · NCT04099966Cannabidiol in Sickle Cell Disease
- Icahn School of Medicine at Mount Sinai, Manhattan
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 giu 2025 · NCT06930703Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.